BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 14556785)

  • 1. 2,4-Diaminopyrimidines as inhibitors of Leishmanial and Trypanosomal dihydrofolate reductase.
    Pez D; Leal I; Zuccotto F; Boussard C; Brun R; Croft SL; Yardley V; Ruiz Perez LM; Gonzalez Pacanowska D; Gilbert IH
    Bioorg Med Chem; 2003 Nov; 11(22):4693-711. PubMed ID: 14556785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and testing of 5-benzyl-2,4-diaminopyrimidines as potential inhibitors of leishmanial and trypanosomal dihydrofolate reductase.
    Chowdhury SF; Guerrero RH; Brun R; Ruiz-Perez LM; Pacanowska DG; Gilbert IH
    J Enzyme Inhib Med Chem; 2002 Oct; 17(5):293-302. PubMed ID: 12683746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and evaluation of inhibitors of trypanosomal and leishmanial dihydrofolate reductase.
    Chowdhury SF; Villamor VB; Guerrero RH; Leal I; Brun R; Croft SL; Goodman JM; Maes L; Ruiz-Perez LM; Pacanowska DG; Gilbert IH
    J Med Chem; 1999 Oct; 42(21):4300-12. PubMed ID: 10543874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel inhibitors of Leishmanial dihydrofolate reductase.
    Chowdhury SF; Di Lucrezia R; Guerrero RH; Brun R; Goodman J; Ruiz-Perez LM; Pacanowska DG; Gilbert IH
    Bioorg Med Chem Lett; 2001 Apr; 11(8):977-80. PubMed ID: 11327604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and evaluation of 2,4-diaminoquinazolines as inhibitors of trypanosomal and leishmanial dihydrofolate reductase.
    Khabnadideh S; Pez D; Musso A; Brun R; Pérez LM; González-Pacanowska D; Gilbert IH
    Bioorg Med Chem; 2005 Apr; 13(7):2637-49. PubMed ID: 15755663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel inhibitors of Trypanosoma cruzi dihydrofolate reductase.
    Zuccotto F; Zvelebil M; Brun R; Chowdhury SF; Di Lucrezia R; Leal I; Maes L; Ruiz-Perez LM; Gonzalez Pacanowska D; Gilbert IH
    Eur J Med Chem; 2001 May; 36(5):395-405. PubMed ID: 11451529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydrofolate reductase: a potential drug target in trypanosomes and leishmania.
    Zuccotto F; Martin AC; Laskowski RA; Thornton JM; Gilbert IH
    J Comput Aided Mol Des; 1998 May; 12(3):241-57. PubMed ID: 9749368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The structure-based design and synthesis of selective inhibitors of Trypanosoma cruzi dihydrofolate reductase.
    Zuccotto F; Brun R; Gonzalez Pacanowska D; Ruiz Perez LM; Gilbert IH
    Bioorg Med Chem Lett; 1999 May; 9(10):1463-8. PubMed ID: 10360757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3-Nitrotriazole-based piperazides as potent antitrypanosomal agents.
    Papadopoulou MV; Bloomer WD; Rosenzweig HS; O'Shea IP; Wilkinson SR; Kaiser M
    Eur J Med Chem; 2015 Oct; 103():325-34. PubMed ID: 26363868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deoxyuridine triphosphate nucleotidohydrolase as a potential antiparasitic drug target.
    Nguyen C; Kasinathan G; Leal-Cortijo I; Musso-Buendia A; Kaiser M; Brun R; Ruiz-Pérez LM; Johansson NG; González-Pacanowska D; Gilbert IH
    J Med Chem; 2005 Sep; 48(19):5942-54. PubMed ID: 16161998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the ability of dihydropyrimidine-5-carboxamide and 5-benzyl-2,4-diaminopyrimidine-based analogues for the selective inhibition of L. major dihydrofolate reductase.
    Bibi M; Qureshi NA; Sadiq A; Farooq U; Hassan A; Shaheen N; Asghar I; Umer D; Ullah A; Khan FA; Salman M; Bibi A; Rashid U
    Eur J Med Chem; 2021 Jan; 210():112986. PubMed ID: 33187806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of potent nitrotriazole-based antitrypanosomal agents: In vitro and in vivo evaluation.
    Papadopoulou MV; Bloomer WD; Rosenzweig HS; O'Shea IP; Wilkinson SR; Kaiser M; Chatelain E; Ioset JR
    Bioorg Med Chem; 2015 Oct; 23(19):6467-76. PubMed ID: 26344593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and characterization of potent inhibitors of Trypanosoma cruzi dihydrofolate reductase.
    Schormann N; Velu SE; Murugesan S; Senkovich O; Walker K; Chenna BC; Shinkre B; Desai A; Chattopadhyay D
    Bioorg Med Chem; 2010 Jun; 18(11):4056-66. PubMed ID: 20452776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitors of dihydrofolate reductase in Leishmania and trypanosomes.
    Gilbert IH
    Biochim Biophys Acta; 2002 Jul; 1587(2-3):249-57. PubMed ID: 12084467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipophilic antifolate trimetrexate is a potent inhibitor of Trypanosoma cruzi: prospect for chemotherapy of Chagas' disease.
    Senkovich O; Bhatia V; Garg N; Chattopadhyay D
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3234-8. PubMed ID: 16048931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New 2,4-diamino-5-(2',5'-substituted benzyl)pyrimidines as potential drugs against opportunistic infections of AIDS and other immune disorders. Synthesis and species-dependent antifolate activity.
    Rosowsky A; Forsch RA; Sibley CH; Inderlied CB; Queener SF
    J Med Chem; 2004 Mar; 47(6):1475-86. PubMed ID: 14998335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenothiazine inhibitors of trypanothione reductase as potential antitrypanosomal and antileishmanial drugs.
    Chan C; Yin H; Garforth J; McKie JH; Jaouhari R; Speers P; Douglas KT; Rock PJ; Yardley V; Croft SL; Fairlamb AH
    J Med Chem; 1998 Jan; 41(2):148-56. PubMed ID: 9457238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel dihydrofolate reductase inhibitors. Structure-based versus diversity-based library design and high-throughput synthesis and screening.
    Wyss PC; Gerber P; Hartman PG; Hubschwerlen C; Locher H; Marty HP; Stahl M
    J Med Chem; 2003 Jun; 46(12):2304-12. PubMed ID: 12773035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and antitrypanosomal activities of novel pyridylchalcones.
    Bhambra AS; Ruparelia KC; Tan HL; Tasdemir D; Burrell-Saward H; Yardley V; Beresford KJM; Arroo RRJ
    Eur J Med Chem; 2017 Mar; 128():213-218. PubMed ID: 28189085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and antifolate activity of new analogues of piritrexim and other diaminopyrimidine dihydrofolate reductase inhibitors with omega-carboxyalkoxy or omega-carboxy-1-alkynyl substitution in the side chain.
    Chan DC; Fu H; Forsch RA; Queener SF; Rosowsky A
    J Med Chem; 2005 Jun; 48(13):4420-31. PubMed ID: 15974594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.